4571.T
Nano Holdings,Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 80.00
−3.61%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 155.0M | 174.0M | 108.0M | 135.0M | 202.0M |
| Cost of Revenue | — | 21.2M | 30.4M | 24.6M | 42.6M |
| Gross Profit | — | 153.3M | 78.2M | 111.0M | 159.6M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | 1.1B | 833.5M | 975.4M | 1.4B |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | — | 1.1B | 833.5M | 975.4M | 1.4B |
| Cost and Expenses | 1.0B | 1.1B | 863.0M | 999.0M | 1.4B |
| Operating Income (EBIT) | (872.0M) | (965.0M) | (755.0M) | (864.0M) | (1.2B) |
| Non-Operating | |||||
| Interest Income | — | 33.1M | 31.3M | 26.2M | 25.4M |
| Interest Expense | — | 23.1M | — | — | — |
| Net Interest Income | — | 9.9M | — | — | — |
| Other Non-Op Income/Expense | — | 99.0M | 67.8M | 114.6M | 141.4M |
| Non-Operating Income (excl Interest) | — | 114.7M | 42.0M | 99.8M | 130.6M |
| EBT (Pre-Tax Income) | — | (940.8M) | (832.6M) | (777.5M) | (1.3B) |
| Income Tax Expense | — | 3.2M | 2.8M | 2.5M | 2.5M |
| Bottom Line | |||||
| Net Income | (887.0M) | (943.0M) | (835.0M) | (780.0M) | (1.3B) |
| Earnings from Cont. Ops | — | — | — | — | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (887.0M) | (943.0M) | (835.0M) | (780.0M) | (1.3B) |
| Per Share | |||||
| Basic EPS | (¥13) | (¥13) | (¥12) | (¥11) | (¥19) |
| Diluted EPS | (¥13) | (¥13) | — | — | — |
| Revenue Per Share | ¥2 | ¥2 | ¥2 | ¥2 | ¥3 |
| Shares | |||||
| Basic Shares Outstanding | 71.5M | 73.1M | 70.5M | 70.3M | 70.1M |
| Diluted Shares Outstanding | — | — | — | — | — |
| Profitability Metrics | |||||
| EBITDA | — | (964.5M) | (755.0M) | (862.9M) | (1.2B) |
| D&A | — | 497.0K | 22.0K | 1.1M | 136.0K |
| EBIT | (872.0M) | (965.0M) | (755.0M) | (864.0M) | (1.2B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026